Company description

Pharmaceutical Solutions Industry Ltd (PSI) a member of Ambah Group is the leading sterile injectable manufacturer in Middle East and Africa.

Our manufacturing facilities in Saudi Arabia are GMP certified and equipped with the latest production technologies with over 40 years of proven reliable experience worldwide in contract manufacturing of parenteral solutions in plastic and glass bottles, plastic bags, as well as plastic ampoules.

Recently, Ambah/PSI has developed the first Ibuprofen intravenous (IV) infusion in the world (400mg/100ml). Successfully registered as Ambaprofen and Ambafen (Ibuprofen 400mg/100ml IV Infusion) through the health authorities in Germany, Spain, and Saudi Arabia, its patent has been granted by the European Patent Office (EPO patent no: 2636406) and United States Patent and Trademark Office (uspto Patent No: US 9351926 B2) for its dosage form with the approval of the European Medicines Agency (EMA).

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Agent; Contract Manufacturer; Distributor; Manufacturer
Affiliated categories: Contract Manufacturing |Injectables |Logistics and Distribution More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 2D12 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Contact information




View all contact information